Author
Listed:
- Sara Mucherino
(CIRFF, Center of Drug Utilization and Pharmacoeconomics, University of Naples Federico II, 80131 Naples, Italy
Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy
These authors contributed equally to this work and served as co-first authors.)
- Antonio Gimeno-Miguel
(EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, 50009 Zaragoza, Spain
Health Services Research on Chronic Patients Network (REDISSEC), ISCIII, 28029 Madrid, Spain
These authors contributed equally to this work and served as co-first authors.)
- Jonas Carmona-Pirez
(EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, 50009 Zaragoza, Spain
Health Services Research on Chronic Patients Network (REDISSEC), ISCIII, 28029 Madrid, Spain)
- Francisca Gonzalez-Rubio
(EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, 50009 Zaragoza, Spain
Health Services Research on Chronic Patients Network (REDISSEC), ISCIII, 28029 Madrid, Spain
Drug Utilization Work Group, Spanish Society of Family and Community Medicine (SemFYC), 28004 Madrid, Spain)
- Ignatios Ioakeim-Skoufa
(EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, 50009 Zaragoza, Spain
Drug Utilization Work Group, Spanish Society of Family and Community Medicine (SemFYC), 28004 Madrid, Spain
Vaksinasjonssenter BSN, Bydel Søndre Nordstrand, Oslo Kommune, 1252 Oslo, Norway)
- Aida Moreno-Juste
(EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, 50009 Zaragoza, Spain
Health Services Research on Chronic Patients Network (REDISSEC), ISCIII, 28029 Madrid, Spain)
- Valentina Orlando
(CIRFF, Center of Drug Utilization and Pharmacoeconomics, University of Naples Federico II, 80131 Naples, Italy
Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy)
- Mercedes Aza-Pascual-Salcedo
(EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, 50009 Zaragoza, Spain
Health Services Research on Chronic Patients Network (REDISSEC), ISCIII, 28029 Madrid, Spain)
- Beatriz Poblador-Plou
(EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, 50009 Zaragoza, Spain
Health Services Research on Chronic Patients Network (REDISSEC), ISCIII, 28029 Madrid, Spain)
- Enrica Menditto
(CIRFF, Center of Drug Utilization and Pharmacoeconomics, University of Naples Federico II, 80131 Naples, Italy
Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy
These authors also contributed equally to this work and served as co-lead authors.)
- Alexandra Prados-Torres
(EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, 50009 Zaragoza, Spain
Health Services Research on Chronic Patients Network (REDISSEC), ISCIII, 28029 Madrid, Spain
These authors also contributed equally to this work and served as co-lead authors.)
Abstract
The pressing problem of multimorbidity and polypharmacy is aggravated by the lack of specific care models for this population. We aimed to investigate the evolution of multimorbidity and polypharmacy patterns in a given population over a 4-year period (2011–2015). A cross-sectional, observational study among the EpiChron Cohort, including anonymized demographic, clinical and drug dispensation information of all users of the public health system ≥65 years in Aragon (Spain), was performed. An exploratory factor analysis, stratified by age and sex, using an open cohort was carried out based on the tetra-choric correlations among chronic diseases and dispensed drugs during 2011 and compared with 2015. Seven baseline patterns were identified during 2011 named as: mental health, respiratory, allergic, mechanical pain, cardiometabolic, osteometabolic, and allergic/derma. Of the epidemiological patterns identified in 2015, six were already present in 2011 but a new allergic/derma one appeared. Patterns identified in 2011 were more complex in terms of both disease and drugs. Results confirmed the existing association between age and clinical complexity. The systematic associations between diseases and drugs remain similar regarding their clinical nature over time, helping in early identification of potential interactions in multimorbid patients with a high risk of negative health outcomes due to polypharmacy.
Suggested Citation
Sara Mucherino & Antonio Gimeno-Miguel & Jonas Carmona-Pirez & Francisca Gonzalez-Rubio & Ignatios Ioakeim-Skoufa & Aida Moreno-Juste & Valentina Orlando & Mercedes Aza-Pascual-Salcedo & Beatriz Pobla, 2021.
"Changes in Multimorbidity and Polypharmacy Patterns in Young and Adult Population over a 4-Year Period: A 2011–2015 Comparison Using Real-World Data,"
IJERPH, MDPI, vol. 18(9), pages 1-20, April.
Handle:
RePEc:gam:jijerp:v:18:y:2021:i:9:p:4422-:d:540680
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:9:p:4422-:d:540680. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.